Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Vollert

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 27, 2025
Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) studyLysia Demetriou, Danielle Perro, Lydia Coxon, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Pain|March 19, 2026
Women with chronic pelvic pain can be stratified using multimodal assessmentLysia Demetriou, Lydia Coxon, Emma Evans, et al.
Pain|January 10, 2024
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerationsSimon Haroutounian, Katherine J Holzer, Robert D Kerns, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|March 17, 2021
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent painNadia Soliman, Simon Haroutounian, Andrea G Hohmann, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 29, 2024
Genetic associations of neuropathic pain and sensory profile in a deeply phenotyped neuropathy cohortMikael Åkerlund, Georgios Baskozos, Wenqianglong Li, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Trials|September 5, 2022
IMI2-PainCare-BioPain-RCT2 protocol: a randomized, double-blind, placebo-controlled, crossover, multicenter trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by non-invasive neurophysiological measurements of human spinal cord and brainstem activityCaterina Leone, Giulia Di Stefano, Giuseppe Di Pietro, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 27, 2025
Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) studyLysia Demetriou, Danielle Perro, Lydia Coxon, et al.
Trials|February 20, 2022
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)Zahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Anesthesiology|August 4, 2025
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjectsZahra Nochi, Hossein Pia, Petra Bloms-Funke, et al.
Pain|March 19, 2026
Women with chronic pelvic pain can be stratified using multimodal assessmentLysia Demetriou, Lydia Coxon, Emma Evans, et al.
Pain|January 10, 2024
Patient engagement in designing, conducting, and disseminating clinical pain research: IMMPACT recommended considerationsSimon Haroutounian, Katherine J Holzer, Robert D Kerns, et al.
Pain|May 9, 2024
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statementDavid Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|March 17, 2021
Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent painNadia Soliman, Simon Haroutounian, Andrea G Hohmann, et al.
Pain|March 21, 2023
Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statementDavid J Hohenschurz-Schmidt, Dan Cherkin, Andrew S C Rice, et al.
Pain|October 29, 2024
Genetic associations of neuropathic pain and sensory profile in a deeply phenotyped neuropathy cohortMikael Åkerlund, Georgios Baskozos, Wenqianglong Li, et al.
Pageof 14